Sanofi pledges new 1 billion euros worth of investments in French production sites
PARIS (Reuters) - Sanofi on Monday announced it would invest over 1 billion euros ($1.1 billion) to create new medicines and ...
May 13, 2024
Analysis-Before global scrutiny, Indian spice maker MDH faced many US rejections
By Rishika Sadam HYDERABAD, India (Reuters) - Popular Indian spice brand MDH, under scrutiny for alleged contamination in som...
May 12, 2024
Fresenius Medical sees up to 2% US dialysis growth by year-end
FRANKFURT (Reuters) - The number of kidney dialysis sessions provided by Fresenius Medical Care in its top market, the United...
May 11, 2024
Final tests of US dairy samples are negative for bird flu virus, US FDA says
CHICAGO (Reuters) - Final testing of U.S. retail dairy samples came back negative for viable H5N1 bird flu virus, the Food an...
May 10, 2024
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and relat...
May 10, 2024
US to provide nearly $200 million to contain bird flu spread on dairy farms
By Leah Douglas WASHINGTON (Reuters) - The Biden administration said on Friday it will provide nearly $200 million to fight t...
May 10, 2024
Italy updates IVF rules to allow access for widowed or separated women
ROME (Reuters) - Italy's Health Ministry has updated its guidelines on medically assisted reproduction, allowing access for w...
May 10, 2024
Pandemic treaty talks to the wire, likely to miss first deadline, sources say
By Jennifer Rigby LONDON (Reuters) - Talks to draw up a global pact to help fight future pandemics are likely to miss an init...
May 10, 2024
UK's CMA kicks off probe into Thermo Fisher-Olink deal
(Reuters) - Britain's competition regulator said on Friday it has initiated a probe into U.S. medical equipment maker Thermo ...
May 10, 2024
US FDA pushes decision on Moderna's RSV vaccine to end of this month
(Reuters) - The U.S. Food and Drug Administration has pushed back its decision on Moderna's respiratory syncytial virus (RSV)...
May 10, 2024